基于siRNA的方法用于割抗性前列腺癌治疗,向雄激素受体信号通路
Yanling Yu1, Dimitri Papukashvili2, Ruimin Ren3
1Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, 030001, China.
Future oncology (London, England)
|October 12, 2023
概括
前列腺癌中抗雄激素剥夺治疗的耐药性是由雄激素受体 (AR) 路径激活驱动的. 小干扰RNA (siRNA) 提供了一个有前途的向疗法,用于割抵抗性前列腺癌 (CRPC).
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 抗雄激素剥夺疗法 (ADT) 是转移性前列腺癌的主要治疗方法.
- 抗ADT耐药性往往导致割抵抗性前列腺癌 (CRPC),由雄激素受体 (AR) 路径激活驱动.
- 目前针对AR的疗法面临着由于AR基因过度表达,突变和拼接变异的挑战.
研究的目的:
- 审查前列腺癌的进展情况和AR信号在CRPC中的作用.
- 探索小干扰RNA (siRNA) 作为CRPC的向治疗的潜力.
主要方法:
- 关于前列腺癌进展的文献综述.
- 对CRPC中AR信号通路的分析.
- 评估siRNA作为一种治疗策略.
主要成果:
- 在前列腺癌管理中,ADT耐药性是一个重要的临床挑战.
- AR信号通路的失调是CRPC发展的核心.
- siRNA技术为向CRPC治疗提供了一种新的方法.
结论:
- 对于CRPC而言,有必要制定新的治疗策略.
- 基于siRNA的疗法在克服ADT耐药性方面具有显著的前景.
- 用siRNA准AR途径为CRPC提供了一种特定且有效的方法.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K


